JPRN-jRCT2051220152招募中1 期
A clinical trial of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patients for single and repeated dose - Phase I/IIa, clinical pharmacology study, exploratory study
Koji Oka0 个研究点目标入组 134 人开始时间: 2023年1月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •18 years of age or older
- •- Male or Female
- •- Both eyes diagnosed as having dry eye
排除标准
- •- Any corneal and conjunctival abnormalities or other diseases other than dry eye affecting the ocular surface
- •- Having eye disease requiring treatment other than dry eye.
- •- Anatomically and functionally abnormal eyelids (e.g. Eyelid closure failure)
- •- Anyone otherwise considered unsuitable for the study by the investigators
研究者
相似试验
已完成
1 期
A phase I study of STN1013400 ophthalmic solution in healthy adult male volunteerMyopiaJPRN-jRCT2031210208Migita Yukie48
已完成
1 期
A phase I study of STN1013600 ophthalmic solution in healthy adult male volunteerPresbyopiaJPRN-jRCT2031210614Migita Yukie24
已完成
1 期
Pharmacokinetic study of STN1012600 ophthalmic solution in healthy adult males volunteersJPRN-jRCT2051230035Koji Oka8
已完成
2 期
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)Fuchs Endothelial Corneal DystrophyNCT05376176Santen Inc.86
已完成
2 期
Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With PresbyopiaPresbyopiaNCT05665387Santen Inc.79